Your Cart Is Empty!
- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The Belgian biotechnology industry had total revenues of $7.8bn in 2014, representing a compound annual growth rate (CAGR) of 7% between 2010 and 2014.
- The medical/healthcare segment was the industrys most lucrative in 2014, with total revenues of $6.0bn, equivalent to 76.4% of the industrys overall value.
- The performance of the industry is forecast to accelerate, with an anticipated CAGR of 8.8% for the five-year period 2014 - 2019, which is expected to drive the industry to a value of $11.9bn by the end of 2019.
Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in Belgium
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Belgium
Leading company profiles reveal details of key biotechnology market players global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Belgium biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Belgium economy
Reasons To Buy
What was the size of the Belgium biotechnology market by value in 2014?
What will be the size of the Belgium biotechnology market in 2019?
What factors are affecting the strength of competition in the Belgium biotechnology market?
How has the market performed over the last five years?
Table of Contents
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
AstraZeneca PLC 19
Novartis AG 22
Sanofi SA 26
ThromboGenics NV 30
Macroeconomic Indicators 33
Country Data 33
Industry associations 36
Related MarketLine research 36
About MarketLine 37
LIST OF TABLES
Table 1: Belgium biotechnology industry value: $ billion, 2010-14(e) 8
Table 2: Belgium biotechnology industry category segmentation: $ billion, 2014(e) 9
Table 3: Belgium biotechnology industry geography segmentation: $ billion, 2014(e) 10
Table 4: Belgium biotechnology industry value forecast: $ billion, 2014-19 11
Table 5: AstraZeneca PLC: key facts 19
Table 6: AstraZeneca PLC: key financials ($) 20
Table 7: AstraZeneca PLC: key financial ratios 20
Table 8: Novartis AG: key facts 22
Table 9: Novartis AG: key financials ($) 23
Table 10: Novartis AG: key financial ratios 24
Table 11: Sanofi SA: key facts 26
Table 12: Sanofi SA: key financials ($) 27
Table 13: Sanofi SA: key financials (Euro) 27
Table 14: Sanofi SA: key financial ratios 28
Table 15: ThromboGenics NV: key facts 30
Table 16: ThromboGenics NV: key financials ($) 30
Table 17: ThromboGenics NV: key financials (Euro) 31
Table 18: ThromboGenics NV: key financial ratios 31
Table 19: Belgium size of population (million), 2010-14 33
Table 20: Belgium gdp (constant 2005 prices, $ billion), 2010-14 33
Table 21: Belgium gdp (current prices, $ billion), 2010-14 33
Table 22: Belgium inflation, 2010-14 34
Table 23: Belgium consumer price index (absolute), 2010-14 34
Table 24: Belgium exchange rate, 2010-14 34
LIST OF FIGURES
Figure 1: Belgium biotechnology industry value: $ billion, 2010-14(e) 8
Figure 2: Belgium biotechnology industry category segmentation: % share, by value, 2014(e) 9
Figure 3: Belgium biotechnology industry geography segmentation: % share, by value, 2014(e) 10
Figure 4: Belgium biotechnology industry value forecast: $ billion, 2014-19 11
Figure 5: Forces driving competition in the biotechnology industry in Belgium, 2014 12
Figure 6: Drivers of buyer power in the biotechnology industry in Belgium, 2014 13
Figure 7: Drivers of supplier power in the biotechnology industry in Belgium, 2014 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Belgium, 2014 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Belgium, 2014 17
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Belgium, 2014 18
Figure 11: AstraZeneca PLC: revenues and profitability 21
Figure 12: AstraZeneca PLC: assets and liabilities 21
Figure 13: Novartis AG: revenues and profitability 24
Figure 14: Novartis AG: assets and liabilities 25
Figure 15: Sanofi SA: revenues and profitability 28
Figure 16: Sanofi SA: assets and liabilities 29
Figure 17: ThromboGenics NV: revenues and profitability 31
Figure 18: ThromboGenics NV: assets and liabilities 32
Following are different modes of Licenses.
a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.
b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.
c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.
1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :
a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]
b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]
2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:
a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.